Therapeutic proteins- focus on analysis and formulation

The main purpose of the symposium is to review the state of the art of analytical tools and formulation concepts as applied to therapeutic proteins, and to highlight the needs of new innovative solutions for remaining problems.

Streaming

Streaming means that the course will be recorded live and broadcast in a stream on the internet. This allows you to sit in your workplace and do this symposium. The streamed version of this training is exactly the same as the physical one and you can ask questions in the chat for streaming when the training is in progress.

Therapeutic proteins

Therapeutic proteins represent an area under rapid development. In fact, biologics globally dominate clinical trials and registrations of new pharmaceutical drugs. Large investments for research and development are currently being made in many countries. In Sweden, the government, the Wallenberg Foundation and several pharmaceutical companies have recently funded large research programs in the area. Therapeutic proteins are often developed for very serious and sometimes life-threatening illnesses like congenital genetic diseases, cancer and immunological disorders. The size and complexity of the molecules require development of new analytical techniques and formulation concepts that are often fundamentally different from those applied to conventional small molecular drugs.

Program

Day 1: February 5, 09.30 hrs with registration. The program starts at 10.20 hrs
Session 1: Novel techniques and methods for therapeutic proteins
Koen Sandra, Research Institute for Chromatography, Belgium
Sebastian Hansson, Solve, Sweden
Stefan Ulvenlund, Enza Biotech AB, Sweden
Session 2: Purity determinations
Margareta Ramström, Medical Product Agency, Sweden
Christian Neusüss, University of Aalen, Germany
Session 3: Registration aspects
Mats Welin, Medical Product Agency, Sweden
Session 4: Biophysical characterization
Torgny Fornstedt, Karlstad University, Sweden
Natalia Markova, Microcal, Malvern Instruments Ltd, Sweden

Symposium dinner

Day 2: February 6, 08.30 hrs
Session 5: Biosimilars
TBD
Session 6: Stability and aggregation studies
Christine Lagerquist Hägglund, Sobi, Sweden
Helen Sjögren, Ferring Pharmaceuticals, Denmark
Jonas Fransson, Sobi, Sweden
Ulla Elofsson, Research Institutes of Sweden – RISE
Anna Millqvist Fureby, NextBioForm, Research Institutes of Sweden –

Who should attend?

This symposium will be of interest to people working with research and development of therapeutic proteins in the Academia, Industry and Government authorities.

Schedule

 The symposium program and its streaming startsTuesday February 5 at 10.20 hrs. On Wednesday February 6, the symposium starts at 08.30 hrs. The program ends at approximately 12.45 hrs. The official language is English.

Registration fees

The participation fee for Industry and private company delegates is 5000 SEK and for Academy and authorities 4000 SEK. For those who are PhD students the fee is 2000 SEK.
Included in the fees are a digital abstract book. R>All prices are excluding VAT.

You will get access to a login link before the course starts and will have access to all streamed lectures for 1 month after the course.

 To register to the physical course, please follow this link: https://www.lakemedelsakademin.se/produkt/therapeutical-proteins-focus-on-analysis-and-formulations/?lang=en

Organizing committee

Douglas Westerlund, Uppsala University; Stefan Ulvenlund, Enza Biotech AB; Brita Rippner, Chiesi Pharma AB; Jonas Bergquist, Uppsala University; Ahmad Amini, Medical Products Agency; Sara Richardsson, AstraZeneca; Sophie Hoas, Swedish Academy of Pharmaceutical Sciences; Lisa Bandholtz, Swedish Pharmaceutical Society